1. Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C in adults previously vaccinated with inactivated vaccine: A randomized, double-blind, placebo-controlled phase 1/2 clinical trial. Issue 2 (February 2023) Authors: Hannawi, Suad; Saifeldin, Linda; Abuquta, Alaa; Alamadi, Ahmad; Mahmoud, Sally A.; Li, Jian; Chen, Yuanxin; Xie, Liangzhi Journal: Journal of infection Issue: Volume 86:Issue 2(2023) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗